methyl 4-((3-methyl-1,2,4-oxadiazol-5-yl)methoxy)benzoate, 95.0%, 250mg

5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 5g

Bromoacetaldehyde Dimethyl Acetal (stabilized with K2CO3)>97.0%(GC)500g

4-Bromo-2-iodo-6-nitroaniline, 95.0%, 5g

[(2E)-3-(2-methoxyphenyl)prop-2-en-1-yl](prop-2-en-1-yl)amine hydrochloride, 95.0%, 10g

1-(2-bromophenyl)-6-chloro-1-oxohexane, 97.0%, 1g

2-Coumaranone>98.0%(GC)25g

Ethyl (2Z)-2-cyano-3-[(methylcarbamoyl)amino]prop-2-enoate, 250mg

(S)-1-Boc-3-N-(Pyridin-4-ylmethyl)-amino-piperidine, 97.0%, 1g

Cbz-L-tert-Leucine, 95.0%, 100g

8-Bromoisochroman-4-one, 98%, 250mg

3-aminobenzoic acid, >=98%, for synthesis, 50 g, plastic packaging.

2',5'-dimethyl-3-(2-methoxyphenyl)propiophenone, 97.0%, 1g